With your risk of dementia post stroke, how is your doctor objectively determining if you have it? NOTHING LIKE USUAL? Then you don't have a functioning stroke doctor. Run away.
Your risk of dementia, has your doctor told you of this? Your doctor is responsible for preventing this!
1. A documented 33% dementia chance post-stroke from an Australian study? May 2012.
2. Then this study came out and seems to have a range from 17-66%. December 2013.`
3. A 20% chance in this research. July 2013.
4. Dementia Risk Doubled in Patients Following Stroke September 2018
The latest here:
Quanterix launches blood test to detect early Alzheimer’s disease
Quanterix Corporation announced the launch of LucentAD, a test to assist in the evaluation of patients experiencing cognitive symptoms consistent with signs of early Alzheimer’s disease.
According to a release from Quanterix, the LucentAD test — which is expected to become available to health care providers for use in conjunction with other diagnostic tools — will provide clinicians with a simplified assessment process to determine whether a patient presents with amyloid pathology consistent with AD.
The LucentAD test measures the protein p-Tau 18 and its concentration in both plasma and cerebrospinal fluid, whose presence correlates to amyloid pathology in the brain. LucentAD uses the Simoa p-Tau 181 assay, whose high analytical sensitivity allows for detection of p-Tau 181, which is a low-abundance protein in blood.
“A year ago, Quanterix announced the validation of our laboratory developed test to quantitatively measure p-Tau 181 in plasma as an aid in diagnostic evaluation of Alzheimer’s disease,” Masoud Toloue, CEO at Quanterix, stated in the release. “The launch of Lucent Diagnostics and availability of the LucentAD test expands access to our p-Tau 181 test for health care providers and marks an important step in our goal to help build a global Alzheimer’s disease testing infrastructure.”
No comments:
Post a Comment